Centanafadine
Centanafadine is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that is being investigated for the treatment of attention deficit hyperactivity disorder (ADHD). It is known for its unique pharmacological profile, which involves the inhibition of the reuptake of three key neurotransmitters: serotonin, norepinephrine, and dopamine.
Pharmacology[edit | edit source]
Centanafadine works by inhibiting the reuptake of serotonin, norepinephrine, and dopamine, which increases the levels of these neurotransmitters in the synaptic cleft and enhances neurotransmission. This mechanism is believed to contribute to its therapeutic effects in managing symptoms of ADHD.
Mechanism of Action[edit | edit source]
The drug's mechanism of action involves binding to the transporters responsible for the reuptake of serotonin, norepinephrine, and dopamine. By inhibiting these transporters, centanafadine increases the concentration of these neurotransmitters in the synaptic cleft, thereby enhancing their activity in the brain.
Clinical Trials[edit | edit source]
Centanafadine has undergone several clinical trials to evaluate its efficacy and safety in treating ADHD. These trials have shown promising results, indicating that centanafadine may be an effective treatment option for individuals with ADHD.
Side Effects[edit | edit source]
As with any medication, centanafadine may cause side effects. Common side effects observed in clinical trials include insomnia, dry mouth, headache, and nausea. It is important for patients to discuss potential side effects with their healthcare provider.
Comparison with Other ADHD Medications[edit | edit source]
Centanafadine is distinct from other ADHD medications such as methylphenidate and amphetamine-based treatments due to its triple reuptake inhibition mechanism. This unique profile may offer advantages in terms of efficacy and side effect profile.
Future Directions[edit | edit source]
Ongoing research is focused on further understanding the long-term effects and potential benefits of centanafadine in treating ADHD. Additional studies are needed to fully establish its place in the therapeutic landscape for ADHD.
See Also[edit | edit source]
- Attention deficit hyperactivity disorder
- Serotonin-norepinephrine-dopamine reuptake inhibitor
- Serotonin
- Norepinephrine
- Dopamine
- Methylphenidate
- Amphetamine
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
